New study from Harvard examines gender differences in obtaining first NIH research award

IMAGE: Journal of Women's Health , published monthly, is a core multidisciplinary journal dedicated to the diseases and conditions that hold greater risk for or are more prevalent among women, as well... view New Rochelle, NY, Oct.2, 2017 -- A study of more than 5,400 instructors and assistant professors at Harvard Medical School compared differences between males and females for receipt of their first National Institutes of Health research award. The study, which also examined gender differences in numbers of publications, h-index, size of coauthor networks, and becoming an assistant professor, is published in Journal of Women's Health , a peer-reviewed publication from Mary Ann Liebert, Inc., publishers .

The benefits & dangers when genetic testing companies partner with orphan drug developers

IMAGE: Genetic Testing and Molecular Biomarkers reports on all aspects of genetic testing, including molecular and biochemical based tests and varied clinical situations; ethical, legal, social, and economic aspects of genetic... view New Rochelle, NY, September 27, 2017-Pharmaceutical companies developing Orphan Drugs are increasingly partnering with direct-to-consumer genetic testing firms to identify individuals with rare diseases, in a trend that is raising concerns related to privacy, drug costs, and rising healthcare-related financial burden for consumers.